title: Tadalafil improves quality of life and exercise tolerance in idiopathic pulmonary arterial hypertension.
abstract: Pulmonary arterial hypertension has a poor prognosis quoad vitam et valitudinem. Herein, we report on a middle-aged woman affected by idiopathic pulmonary arterial hypertension whose quality of life and exercise tolerance improved remarkably after a six-month course of treatment with the long-acting phosphodiesterase-5 inhibitor tadalafil.
authors.forename: Flora
authors.initials: F
authors.lastname: Affuso
authors.forename: Emiliano Antonio
authors.initials: EA
authors.lastname: Palmieri
authors.forename: Pasquale
authors.initials: P
authors.lastname: Di Conza
authors.forename: Vincenzo
authors.initials: V
authors.lastname: Guardasole
authors.forename: Serafino
authors.initials: S
authors.lastname: Fazio
mesh_terms: D000328:Adult; D002243:Carbolines / Q000627:therapeutic use*; D017079:Exercise Tolerance / Q000187:drug effects*; D005260:Female; D006439:Hemodynamics; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy* / Q000503:physiopathology; D010100:Oxygen / Q000097:blood; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use*; D011788:Quality of Life; D000068581:Tadalafil
chemical_list: D002243:Carbolines; D010726:Phosphodiesterase Inhibitors; D000068581:Tadalafil; D010100:Oxygen